List of Companies Profiled in the Report
Agilent Technologies
Caribou Biosciences, Inc.
Cellectis
Cibus Inc.
CRISPR Therapeutics
Danaher Corporation
Editas Medicine
GenScript
Intellia Therapeutics Inc.
Lonza
Merck KGaA
Precision Biosciences
Recombinetics
Revvity
Sangamo Therapeutics
Takara Bio Inc.
Tecan Trading AG
Thermo Fisher Scientific Inc.

List of Other Companies Mentioned in the Report
2Blades
Acuity Swine Genetics
Adva Biotechnology Ltd.
AstraZeneca
Bayer Crop Science
BetterSeeds
BGI Genomics
C4U
Calyxt. Inc.
Capsida Biotherapeutics Inc.
Caribou Biosciences
Cellectis
Chroma Medicine
Cibus, Inc.
Codiak BioSciences
CRV Holding
Element Biosciences, Inc.
Eli Lilly
ERS Genomics
GenKOre, Inc.
Genomedia Inc.
GlaxoSmithKline Plc
Graphite Bio
Harpe Bioherbicide Solutions, Inc.
Healiva
Hebei Senlang Biotechnology
Hendrix Genetics
Immatics
Integrated DNA Technologies Inc (U.S.)
Intellia Therapeutics
Lemonex
Mammoth Biosciences
MedGenome
NAPIGEN
Neurocrine Biosciences
NGS specialists
Nkarta
PacBio
Paramit Corporation
PerkinElmer
Pfizer
Rasi Seeds
Recepta Biopharma
Regeneron Pharmaceuticals
Replace Therapeutics
Richter-Helm BioLogics GmbH & Co. KG
Ricoh Company
Roche
Scribe Therapeutics
Seamless Therapeutics
Shandong Shunfeng Biotechnology Co., Ltd.
Shoreline Biosciences
Singular Genomics
SION
Solidaridad
Sophia Genetics
Stevanato Group S.p.A.
Sumitomo Pharma (Japan)
Takara Bio USA, Inc.
Tome Biosciences
Topigs Norsvin
Vertex Pharmaceuticals
Verve Therapeutics Inc.
ViaCyte, Inc.
VJ Group
Voyager Therapeutics

List of Associations Mentioned in the Report
Advanced Cell Therapy and Research Institute, Singapore (ACTRIS)
American Society of Gene & Cell Therapy (ASGCT)
Australian Biotechnology Association
British government
Broad Institute
Broad Institute of MIT
Canadian Institute of Health Research Institute of Genetics
Carlos Slim Center for Health Research
Carlos Slim Foundation and the Broad Institute
Center for Aquaculture Technologies (CAT)
Center for Genomic Regulation Strategic Plan
Center for Network Research on Rare Diseases (CIBERER)
Development of National Plans for Rare Diseases(EUROPLAN)
European Commission
European Medicines Agency (EMA)
Federated European Genome-Phenome Archive (Federated EGA)
Foreign Agricultural Service Brazil
Foreign Agricultural Services US Department of Agriculture
French Health Technology Assessment Agency
French Ministry of Health and Prevention and the Ministry of Higher Education and Research
French Society for Predictive and Personalized Medicine (SFMPP)
Genome Institute of Singapore
Global Cancer Observatory
Global Institute of Stem Cell Therapy and Research (GIOSTAR)
Government of Canada
Government of UAE
Huada Genomics Institute
Imperial College Healthcare NHS Trust
Institute of Medical Science at the University of Tokyo
International Service for the Acquisition of Agri-biotech Applications (ISAAA)
International Vaccine Institute (IVI)
Italian Ministry of Economy
King Abdulaziz City for Science and Technology (KACST)
Korea University
Kyushu University
McGill University in Montreal
Medical Device Innovation Consortium (MDIC)
Medicines and Healthcare Products Regulatory Agency (MHRA)
Ministry of Agriculture, Forestry and Fisheries (MAFF)
Ministry of Economy, Trade and Industry (METI)
Ministry of Health and Prevention (MoHAP)
Ministry of Health, Labour and Welfare of Japan (MHLW)
Ministry of the Environment
MoH-National Center for Disease Prevention and Control
Nagoya University
Nagoya University School of Medicine
Nanyang Technological University
National Biosafety Commission
National Bureau of Statistics, China
National Institutes of Health (NIH)
National Institutes of Health’s
National Natural Science Foundation of China (NSFC)
Secretariat of Health (SALUD)
South African Stem Cell Transplant Society
Tokyo Metropolitan Institute of Medical Science
U.K. Medicines and Healthcare products Regulatory Agency (MHRA)
U.S. Food and Drug Administration (FDA)
World Health Organization (WHO)